Cargando…

The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kun, Chen, Siyu, Wu, Yue, Wang, Yang, Lu, Yousheng, Sun, Yanzi, Chen, Yijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244432/
https://www.ncbi.nlm.nih.gov/pubmed/37280198
http://dx.doi.org/10.1038/s41419-023-05877-y
_version_ 1785054638855159808
author Wang, Kun
Chen, Siyu
Wu, Yue
Wang, Yang
Lu, Yousheng
Sun, Yanzi
Chen, Yijun
author_facet Wang, Kun
Chen, Siyu
Wu, Yue
Wang, Yang
Lu, Yousheng
Sun, Yanzi
Chen, Yijun
author_sort Wang, Kun
collection PubMed
description Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report the dissection of ufmylating process of RPL10 and potential roles of RPL10 ufmylation in PAAD development. The ufmylation of RPL10 was confirmed in both pancreatic patient tissues and cell lines, and specific modification sites were identified and verified. Phenotypically, RPL10 ufmylation significantly increased cell proliferation and stemness, which is principally resulted from higher expression of transcription factor KLF4. Moreover, the mutagenesis of ufmylation sites in RPL10 further demonstrated the connection of RPL10 ufmylation with cell proliferation and stemness. Collectively, this study reveals that PRL10 ufmylation plays an important role to enhance the stemness of pancreatic cancer cells for PAAD development.
format Online
Article
Text
id pubmed-10244432
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102444322023-06-08 The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma Wang, Kun Chen, Siyu Wu, Yue Wang, Yang Lu, Yousheng Sun, Yanzi Chen, Yijun Cell Death Dis Article Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report the dissection of ufmylating process of RPL10 and potential roles of RPL10 ufmylation in PAAD development. The ufmylation of RPL10 was confirmed in both pancreatic patient tissues and cell lines, and specific modification sites were identified and verified. Phenotypically, RPL10 ufmylation significantly increased cell proliferation and stemness, which is principally resulted from higher expression of transcription factor KLF4. Moreover, the mutagenesis of ufmylation sites in RPL10 further demonstrated the connection of RPL10 ufmylation with cell proliferation and stemness. Collectively, this study reveals that PRL10 ufmylation plays an important role to enhance the stemness of pancreatic cancer cells for PAAD development. Nature Publishing Group UK 2023-06-07 /pmc/articles/PMC10244432/ /pubmed/37280198 http://dx.doi.org/10.1038/s41419-023-05877-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wang, Kun
Chen, Siyu
Wu, Yue
Wang, Yang
Lu, Yousheng
Sun, Yanzi
Chen, Yijun
The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
title The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
title_full The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
title_fullStr The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
title_full_unstemmed The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
title_short The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
title_sort ufmylation modification of ribosomal protein l10 in the development of pancreatic adenocarcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244432/
https://www.ncbi.nlm.nih.gov/pubmed/37280198
http://dx.doi.org/10.1038/s41419-023-05877-y
work_keys_str_mv AT wangkun theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT chensiyu theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT wuyue theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT wangyang theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT luyousheng theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT sunyanzi theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT chenyijun theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT wangkun ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT chensiyu ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT wuyue ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT wangyang ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT luyousheng ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT sunyanzi ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma
AT chenyijun ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma